Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Basel, Switzerland

About this trial

The aim of this study is to evaluate whether a new test using mannitol infusion can diagnose the cause of polyuria-polydipsia syndrome as accurately as the current standard test (hypertonic saline infusion) and to compare which test patients prefer. The goal is to identify a simpler and more patient-friendly diagnostic approach.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Hypotonic polyuria/polydipsia syndrome defined as polyuria >40ml/kg body weight/24h and polydipsia >3l/24h; and urine osmolality <800mOsm/L or known AVP-D based on accepted criteria

Disqualifiers

Polyuria/polydipsia secondary to diabetes mellitus, hypercalcemia, or hypokalemia

Diagnosis of AVP-R (Copeptin > 21.4 pmol/L)

Evidence of acute illness

Epilepsy requiring treatment

Trial design

Treatments tested in this trial

  • Mannitol
  • Hypertonic Saline

Treatment groups

144 Participants
are divided into 2 treatment groups